Janone Inc. (NASDAQ:ALTS - Get Free Report) saw a significant increase in short interest in December. As of December 15th, there was short interest totalling 126,700 shares, an increase of 57.0% from the November 30th total of 80,700 shares. Currently, 1.0% of the company's stock are short sold. Based on an average daily volume of 175,400 shares, the days-to-cover ratio is currently 0.7 days.
Janone Price Performance
Shares of NASDAQ ALTS traded up $0.12 on Friday, hitting $4.45. The company had a trading volume of 210,709 shares, compared to its average volume of 236,021. The company has a debt-to-equity ratio of 1.96, a current ratio of 0.75 and a quick ratio of 0.75. Janone has a 12-month low of $0.50 and a 12-month high of $5.26. The company has a 50 day moving average price of $2.86.
Janone Company Profile
(
Get Free Report)
JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.
Featured Articles
Before you consider Janone, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Janone wasn't on the list.
While Janone currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
